State Street’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2015
Q2 | – | Sell |
-583,000
| Closed | -$56.9M | – | 3831 |
|
2015
Q1 | $56.9M | Buy |
583,000
+52,350
| +10% | +$5.11M | 0.01% | 1160 |
|
2014
Q4 | $49.2M | Sell |
530,650
-39,392
| -7% | -$3.65M | ﹤0.01% | 1239 |
|
2014
Q3 | $39.2M | Buy |
570,042
+58,316
| +11% | +$4.01M | ﹤0.01% | 1302 |
|
2014
Q2 | $53.6M | Sell |
511,726
-10,041
| -2% | -$1.05M | 0.01% | 1201 |
|
2014
Q1 | $43.3M | Sell |
521,767
-14,275
| -3% | -$1.18M | ﹤0.01% | 1285 |
|
2013
Q4 | $34.7M | Buy |
536,042
+59,679
| +13% | +$3.86M | ﹤0.01% | 1402 |
|
2013
Q3 | $30.2M | Buy |
476,363
+32,768
| +7% | +$2.07M | ﹤0.01% | 1447 |
|
2013
Q2 | $18.6M | Buy |
+443,595
| New | +$18.6M | ﹤0.01% | 1671 |
|